MedTrace Logo

COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

NCT04787510 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-09-28

No results posted yet for this study

Summary

Effect of Covid-19 disease in clotting factors levels in hospitalized patients

Conditions

  • SARS-COV2 Infection
  • COVID-19 Disease
  • Hospitalized Patients

Interventions

DRUG

low molecular weight Heparin as standard of care treatment

STANDARD OF CARE

Sponsors & Collaborators

  • INTERNAL MEDICINE DEPARTMENT, 1ST WARD

    collaborator UNKNOWN

  • University Hospital, Ioannina

    lead OTHER

Principal Investigators

  • HARALAMPOS MILIONIS, PROFESSOR · University Hospital, Ioannina

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-23
Primary Completion
2021-05-23
Completion
2021-06-23

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04787510 on ClinicalTrials.gov